{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T22:57:26Z","timestamp":1780354646691,"version":"3.54.1"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Therapeutic drug monitoring facilitated the successful outpatient use of low-dosage dalbavancin for treating inoperable staphylococcal abscesses in a patient with chronic granulomatous disease. This approach minimized adverse effects and allowed for effective infection control, highlighting its potential role in complex infectious cases requiring long-term antimicrobial therapy.<\/jats:p>","DOI":"10.1093\/ofid\/ofaf260","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:49:54Z","timestamp":1746060594000},"source":"Crossref","is-referenced-by-count":2,"title":["Bridging to Transplant: TDM-guided Outpatient Dalbavancin Therapy in Chronic Granulomatous Disease With Deep-seeded Inoperable Abscesses Over 11 Months"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8813-5388","authenticated-orcid":false,"given":"Micha","family":"Banz","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Hepatology, and Infectious Diseases, Clinic of Internal Medicine IV, Jena University Hospital , Jena ,","place":["Germany"]},{"name":"Institute for Infectious Diseases and Infection Control, Jena University Hospital , Jena ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2999-6131","authenticated-orcid":false,"given":"Stefan","family":"Hagel","sequence":"additional","affiliation":[{"name":"Institute for Infectious Diseases and Infection Control, Jena University Hospital , Jena ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fritz","family":"S\u00f6rgel","sequence":"additional","affiliation":[{"name":"IBMP-Institute for Biomedical and Pharmaceutical Research , N\u00fcrnberg-Heroldsberg ,","place":["Germany"]},{"name":"Institute of Pharmacology, West German Heart and Vascular Centre, University of Duisburg-Essen , Essen ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Kinzig","sequence":"additional","affiliation":[{"name":"IBMP-Institute for Biomedical and Pharmaceutical Research , N\u00fcrnberg-Heroldsberg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Farker","sequence":"additional","affiliation":[{"name":"Hospital Pharmacy, University Center for Pharmacotherapy and Pharmacoeconomics, Jena University Hospital , Jena ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8157-2753","authenticated-orcid":false,"given":"Mathias W","family":"Pletz","sequence":"additional","affiliation":[{"name":"Institute for Infectious Diseases and Infection Control, Jena University Hospital , Jena ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9865-2629","authenticated-orcid":false,"given":"Karim","family":"Kentouche","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Jena University Hospital , Jena ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"issue":"suppl_1","key":"2025052602121064000_ofaf260-B1","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1093\/jpids\/piy013","article-title":"Infectious complications in patients with chronic granulomatous disease","volume":"7","author":"Bennett","year":"2018","journal-title":"J Pediatric Infect Dis Soc"},{"key":"2025052602121064000_ofaf260-B2","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood-2010-01-264218","article-title":"Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease","volume":"116","author":"Meissner","year":"2010","journal-title":"Blood"},{"key":"2025052602121064000_ofaf260-B3","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/cid\/ciu1154","article-title":"Common severe infections in chronic granulomatous disease","volume":"60","author":"Marciano","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2025052602121064000_ofaf260-B4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0140-6736(13)62069-3","article-title":"Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study","volume":"383","author":"G\u00fcng\u00f6r","year":"2014","journal-title":"Lancet"},{"key":"2025052602121064000_ofaf260-B5","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.jaci.2011.03.028","article-title":"Chronic granulomatous disease: overview and hematopoietic stem cell transplantation","volume":"127","author":"Kang","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"2025052602121064000_ofaf260-B6","doi-asserted-by":"crossref","first-page":"e5234","DOI":"10.1371\/journal.pone.0005234","article-title":"Chronic granulomatous disease: the European experience","volume":"4","author":"van den Berg","year":"2009","journal-title":"PLoS One"},{"issue":"4 PART 1","key":"2025052602121064000_ofaf260-B7","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0022-3476(89)80693-6","article-title":"Incidence, severity, and prevention of infections in chronic granulomatous disease","volume":"114","author":"Mouy","year":"1989","journal-title":"J Pediatr"},{"key":"2025052602121064000_ofaf260-B8","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s40121-024-00933-2","article-title":"Dalbavancin sequential therapy for gram-positive bloodstream infection: a multicenter observational study","volume":"13","author":"Rebold","year":"2024","journal-title":"Infect Dis Ther"},{"key":"2025052602121064000_ofaf260-B9","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s10096-024-04849-0","article-title":"Dalbavancin as suppressive therapy for implant-related infections: a case series with therapeutic drug monitoring and review of the literature","volume":"43","author":"Lafon-Desmurs","year":"2024","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2025052602121064000_ofaf260-B10","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.3390\/antibiotics12111639","article-title":"Long-term suppressive therapeutic-drug-monitoring-guided dalbavancin therapy for cardiovascular prosthetic infections","volume":"12","author":"Gallerani","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"2025052602121064000_ofaf260-B11","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3390\/antibiotics11050541","article-title":"Validation and application of an HPLC-UV method for routine therapeutic drug monitoring of dalbavancin","volume":"11","author":"Chiriac","year":"2022","journal-title":"Antibiotics"},{"key":"2025052602121064000_ofaf260-B12","doi-asserted-by":"crossref","first-page":"e0183024","DOI":"10.1128\/aac.01830-24","article-title":"Usefulness of a hub and spoke TDM-guided expert clinical pharmacological advice program of dalbavancin for optimizing very long-term curative or suppressive treatment of chronic staphylococcal infections","volume":"69","author":"Cojutti","year":"2025","journal-title":"Antimicrob Agents Chemother"},{"key":"2025052602121064000_ofaf260-B13","author":"The European Committee on Antimicrobial Susceptibility Testing"},{"key":"2025052602121064000_ofaf260-B14","first-page":"20499361241245523","article-title":"Dalbavancin as an alternative to traditional outpatient parenteral antimicrobial therapy for deep gram-positive infections\u2013an observational, retrospective review","volume":"11","author":"Bao","year":"2024","journal-title":"Ther Adv Infect Dis"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofaf260\/63034399\/ofaf260.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/5\/ofaf260\/63034399\/ofaf260.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/5\/ofaf260\/63034399\/ofaf260.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T06:12:59Z","timestamp":1748239979000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaf260\/8123042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,4,28]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaf260","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2025,4,28]]},"article-number":"ofaf260"}}